Phibro Animal Health Corporation (FRA:PB8)

Germany flag Germany · Delayed Price · Currency is EUR
34.60
-0.60 (-1.70%)
Last updated: Dec 5, 2025, 8:02 AM CET
55.86%
Market Cap 1.36B
Revenue (ttm) 1.19B
Net Income (ttm) 57.80M
Shares Out n/a
EPS (ttm) 1.42
PE Ratio 23.61
Forward PE 13.82
Dividend 0.43 (1.23%)
Ex-Dividend Date Nov 26, 2025
Volume n/a
Average Volume 38
Open 34.60
Previous Close 35.20
Day's Range 34.60 - 34.60
52-Week Range 14.20 - 39.20
Beta n/a
RSI 45.80
Earnings Date Feb 4, 2026

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1946
Employees 2,475
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PB8
Full Company Profile

Financial Performance

In 2025, Phibro Animal Health's revenue was $1.30 billion, an increase of 27.37% compared to the previous year's $1.02 billion. Earnings were $48.26 million, an increase of 1897.68%.

Financial numbers in USD Financial Statements

News

There is no news available yet.